General: anxiety, agitation, irritability, headache, loss of appetite, nausea. |
Musculature: muscle spasm and tetany. |
CNS/Nerves: nervousness, migraine, depression, poor memory, low-stress tolerance, paraesthesia, tremor, and seizures. |
Cardiovascular system: HTN, a risk of arrhythmias, coronary spasm, atherosclerosis, endothelial dysfunction, low-grade vascular inflammation, arterial stiffness, vascular ECM remodelling, arterial calcification, vascular ageing, increased platelet aggregation potentiates Ca2+-mediated vasoconstriction, potentiates the vasoconstrictor effects of ATII, ET-1, NA, Adr, and TxA2. |
Electrolytes: sodium retention, hypokalemia, and hypocalcemia. |
Metabolism: dyslipoproteinemia, insulin resistance, pancreatic β-cell dysfunction, decreased glucose tolerance, increased risk of MetS and T2D, disorders of vitamin D metabolism, resistance to PTH, and osteoporosis. |
Pregnancy: pregnancy complications (e.g., eclampsia). |
Gastrointestinal tract: constipation. |
jeudi 21 juin 2018
Magnesium
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire